Researchers modeling tumors in cell culture need a technique that faithfully recapitulates the genomic complexity, drug resistance, and metastatic properties of cancer. To do so, they develop organoid cultures that match the characteristics of patient-derived tumor xenografts and use them for cost-effective, high-throughput drug screening efforts.
This Technique Talk will discuss the challenges in breast cancer research and treatment and how to develop new methods and resources for functional precision medicine and cancer drug development.
Learning Objectives
How to develop genomically-diverse breast cancer organoids
Organoids to screen FDA-approved drugs for cancer treatment
How to establish a precision medicine platform in oncology
Tuesday, January 18, 2022
11:30 AM – 12:30 PM Eastern Time
This webinar will also be available on-demand.
Instructor
Alana L. Welm, PhD Senior Director of Basic Science Ralph E. and Willia T. Main Presidential Endowed Chair in Cancer Research Huntsman Cancer Institute Professor, Oncological Sciences University of Utah
Sponsored by
Enroll Now
TS_WEBINARSIGNUP_TSU_Technique Talk: CRISPR for Genome Engineering in Drosophila December 14 2021
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
.png?width=200&name=CROWN_BIO_-_Final_Corporate_Logo_-_RGB_(1).png "sartorius"){kind=logo}
